Altria Group Inc
Most Recent
Will Altria’s Q2 Earnings Be a Boom or Bust?
Analysts expect Altria to report revenues of $5.08 billion in the second quarter of 2020—a fall of 2.2% from $5.19 billion in the second quarter of 2019.
Philip Morris Stock Rose 3 Percent Due to Earnings Surprise
Philip Morris stock has risen as much as 3.2% in the pre-market session today as of 8:55 AM ET. The company posted its second-quarter results.
What to Expect from Philip Morris in Q2
This year, Philip Morris stock has been subdued, losing 13.6% of its value. The company is set to report its second-quarter earnings on July 21.
Barclays Downgrades Altria, Worries about Declining Market Share
Today, Gaurav Jain of Barclays downgraded Altria Group (NYSE:MO) from “overweight” to “equal weight.” He also lowered his target price from $50 to $43.
Philip Morris Stock Rises after FDA Approves IQOS
On Tuesday, the FDA authorized Philip Morris’s IQOS, an electrically heated tobacco unit, to be marketed as a modified risk tobacco product.
Why Philip Morris Looks Attractive at These Levels
So far this year, Philip Morris (NYSE:PM) has lost 17.0% of its stock value. The stock has underperformed the broader equity markets.
Dividend Investors Can Bet on These 2 Consumer Stocks
Procter & Gamble’s strong underlying sales, margin expansion, and consistent dividend growth make it a top stock for income-seeking investors.
How’s COVID-19 Impacting Cigarette and Cannabis Sales?
Layoffs amid COVID-19 led to a decline in disposable income, which had a negative impact on the cigarette and cannabis industries.
How Do Philip Morris and Altria Compare in 2020?
So far this year, Philip Morris International (NYSE:PM) and Altria Group (NYSE:MO) have underperformed the broader equity markets.
Altria Stock Is a No-Brainer with 9.3% Dividend Yield
Investing in Altria stock is a no-brainer considering the company’s solid track record of dividend payments and low valuation.
Is It Time for Investors to Buy Philip Morris?
Despite the impressive first-quarter performance, Philip Morris’s stock price has declined. As of May 7, the company was trading at $70.14.
Raymond James Downgraded Cronos before Its Q1 Earnings
Cronos Group (NASDAQ:CRON) will likely report its results for the first quarter of fiscal 2020 on May 8 before the market opens.
How Do Analysts Rate Cronos Group?
As of April 29, Cronos Group was trading at 8.63 Canadian dollars—a fall of 4.3% since the company reported its fourth-quarter earnings.
Altria Stock Rises Due to Impressive Q1 Earnings
Today, Altria reported its first-quarter earnings. For the quarter, the company reported an adjusted EPS of $1.09 on net revenues of $5.05 billion.
What Can Investors Expect from Altria’s Q1 Results?
Currently, 14 analysts cover Altria stock. Many analysts have a bullish view on the stock due to its higher dividend yield and lower valuation.
Philip Morris Beats Top and Bottom-Line Estimates in Q1
Philip Morris reported its earnings results for the first quarter of 2020. The company reported an adjusted EPS of $1.21 on revenues of $7.15 billion.
What to Expect from Philip Morris’s Q1 Earnings
As of April 13, Philip Morris (NYSE:PM) was trading at 73.95—a fall of 11.3% since the announcement of its fourth-quarter earnings on February 6.
What to Expect from Cronos Group’s Q4 Earnings Today
Cronos Group will report its fourth-quarter and fiscal 2019 results after the market closes today—a delay from the original date of February 27.
2 High-Yielding Dividend Tobacco Stocks during Downturn
Investors should find safety in high-yielding dividend stocks amid the downturn. Altria and Philip Morris both deliver stable earnings and constant dividends.
Morgan Stanley Upgrades Altria Group to ‘Overweight’
On March 16, Morgan Stanley upgraded Altria Group (NYSE:MO) from “equal weight” to “overweight” with a target price of $49.
Are Philip Morris’s Numbers Attractive in 2020?
As of March 10, Philip Morris (PM) was trading at $84.73—a fall of 0.4% since the beginning of this year. PM has outperformed the broader equity market and its peers.
Should You Consider Buying Altria Group?
As of March 6, Altria Group (NYSE:MO) was trading at $42.15—a fall of 15.9% since the company reported its earnings for the fourth quarter of 2020 on January 30.
Cronos Group Receives Rare ‘Buy’ Rating from MKM Partners
MKM Partners analyst Bill Kirk likes Cronos Group’s healthy cash position, strong track record, and its relationship with Altria (NYSE:MO).
What to Expect from Cronos Group’s Q4 Earnings
Cronos Group will report its fourth-quarter earnings before the market opens on Thursday. Analysts expect double-digit revenue growth sequentially.
Why Is Raymond James Bullish on Cronos Group?
On February 7, Rahul Sarugaser of Raymond James reiterated his “outperform” rating for Cronos Group. He’s optimistic about the partnership with Altria.
Philip Morris Beats Analysts’ Top and Bottom-Line Estimates
Today, Philip Morris reported its fourth-quarter earnings. For the quarter, the company posted an adjusted EPS of $1.22 on revenues of $7.71 billion.
What to Expect from Philip Morris in Q4
Philip Morris will report its Q4 earnings before the market opens on Thursday. Analysts expect the company’s revenue to rise and its adjusted EPS to fall.
Altria Meets Earnings Estimates, Misses on Revenue
Today, Altria Group reported its fourth-quarter earnings, which ended on December 31. For the quarter, the company reported revenue of $6.0 billion.
Why Trump Has Banned Flavored e-Cigarettes
On January 2, as reported by CNBC, the FDA banned most fruit- and mint-flavored nicotine products. The move aims to reduce teen usage of these products.
10 Consumer Stocks for Consistent Dividend Income
In addition to boosting dividends, many consumer stocks saw stellar growth in 2019. Most of these companies outperformed the benchmark index YTD.
Consumer Stocks: 5 Stragglers of 2019
Consumer stocks like Macy’s (M), Kraft Heinz (KHC), Gap (GPS), Altria (MO), and Walgreens (WBA) are lagging the broader markets by a wide margin.
Check Out These Dividend-Paying Consumer Stocks
Most consumer stocks have outperformed the broader markets so far this year amid an improved macroeconomic backdrop and the industry’s defensive nature.
Get Real: New Targets and Turnaround Hopes
In this morning’s edition of our daily market newsletter, Get Real, we looked at Trump’s new tariff targets, a 5G network launch, and turnaround hopes.
Cronos and Altria’s Deal: Does It Make Sense Now?
Cronos Group, one of the more resilient cannabis stocks, hasn’t escaped the gloom in the cannabis sector. It’s down 37.44% year-to-date on the Nasdaq.
Why Citigroup Prefers Altria over Philip Morris
Citigroup has upgraded Altria and downgraded Philip Morris. It expects lower cigarette volume declines and has a favorable outlook on traditional tobacco.
Altria Stock: Inexpensive Valuation, High Dividend Yield
Altria (MO) stock has recovered recently and risen by about 8% in a month. However, the stock has underperformed peers and broader markets this year.
Cronos Group’s Q3 Earnings: What to Expect
Analysts expect Cronos Group to report revenue of $14.62 million Canadian dollars in fiscal Q3 2019. This implies a YoY (year-over-year) rise of 288.74%.
Get Real: Why Is the Market Restless?
In today’s Get Real, we saw Tesla’s plans for China, AMD’s expectations for 2020, the state of crude oil prices, and more.
Cronos Group Joins Altria to Bet on Cannabidiol Market
Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.
Get Real: Roller Coaster Continues This Earnings Season
AT&T stock is prospering, while Netflix’s problems could be rising. We also have the latest earnings including U.S. Steel and Chevron today.
Cannabis Cronos Group: The Company that Won’t Stop Growing
Cronos Group (CRON) is one of the most popular Canadian cannabis companies that is set to become a leader. The company involves in the production and sale of marijuana and the sub-products obtained from marijuana with facilities located across five continents. Moreover, the company was set up in 2012, with tobacco company Altria Group (MO) […]
Altria Gives Juul Labs Update, Stock Gets Beating
When Altria posted its earnings yesterday, things looked positive. However, after news about Juul Labs, MO stock lost momentum and closed 2.6% lower.
Why Altria Could Jump on Its Q3 Earnings Beat
Altria (MO) posted better-than-expected third-quarter earnings results today. As expected, lower cigarette shipment volumes remained a drag.
Altria in Q3: What Analysts Expect from Its Earnings
Altria (MO) is scheduled to report its third-quarter earnings results on October 31. Analysts expect its earnings to continue to improve year-over-year.
Here’s Bernie Sanders’ Plan to Legalize Marijuana
Bernie Sanders released his plan to legalize marijuana in the US. He pledged to declassify marijuana as a controlled substance in the first 100 days.
Altria Stock: Will Sluggishness End with Q3 Earnings?
Altria stock has recovered sharply in October. There’s positive momentum in the stock before the company’s earnings. The stock has risen 14% in October.
Will Altria Erase Its Losses and Turn Positive?
On October 18, Citigroup upgraded Altria stock to “neutral” from “sell.” It expects the negative news surrounding vaping to boost cigarette volumes.
Philip Morris: Earnings Beat, Sales Lag in Q3
Philip Morris reported mixed third-quarter results before the markets opened. The company posted revenues of $7.64 billion—up 1.8% YoY.
Will Philip Morris Stock Jump after Its Q3 Earnings?
Philip Morris will announce its third-quarter earnings results on October 17. We believe the pressure on the company’s top line could ease a bit.
Altria Stock: High Dividend Yield Eases Investors’ Pain
Since the lower stock price dented investors’ return, Altria has rewarded its shareholders through higher dividends and share repurchases.
Juul’s Valuation Cut by Darsana—Will Others Follow?
Many hedge funds have been reaping the benefits of a rise in Juul’s valuation. However, they didn’t foresee a massive potential vaping-related issue.
Cannabis Industry Heats Up, Trump Might Ban Vaping
Cannabis legalization is heating up. More states are coming forward to legalize marijuana. Cannabis is also gaining global popularity.
Why Vaping May Not Be a Gold Mine for Cannabis Players
In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.
Cronos: What’s the Word on Wall Street?
Cronos Group (CRON) reported its Q2 results last month. Despite better-than-expected sales, its Q2 losses widened and its stock has fallen 23% since then.
Vaping Concerns Grow, FDA and FTC Investigate Juul
Vaping has become very popular. However, investigations by the FTC and FDA sparked more concerns. Juul’s vaping devices could cause seizures.
Tobacco Giants Philip Morris and Altria Could Merge
Behemoth tobacco companies Philip Morris (PM) and Altria (MO) might be getting back together after separating more than a decade ago.
Altria’s Dividend Yield Gets More Attractive
On August 23, the markets tumbled due to the escalating trade war. The S&P 500 Index lost around 2.6%. Altria stock held out and lost just 0.4%.
Altria Stock: Key Indicators and Risks
Altria (MO) stock has lagged the broader market in 2019. On August 17, the CDC noted that it is investigating lung diseases linked to e-cigarette use.
Altria: What Will Drive Long-Term Growth?
Altria (MO) stock has dipped roughly 5% so far in 2019, underperforming the broader market. MO stock is trading about 10% above its 52-week low price.
Why These Dividend-Paying Consumer Stocks Look Attractive
As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.
How Will Canopy Growth Capture the US Vaping Market?
On Thursday, Canopy Growth announced its entry into the US vaporizer market. The company entered into a distribution agreement with Greenlane Holdings.
Vaping Cannabis or Smoking Tobacco: Burning Questions
During its latest earnings call, Aphria (APHA) stated that vapes and concentrates could form a major share of Canada’s recreational market by 2021.
Altria’s Growth Prospects and Valuation
This year, Altria (MO) expects its adjusted EPS to grow 4%–7% year-over-year to $4.15–$4.27. It’s investing in product expansion and loyalty programs.
Why Altria Stock Fell after Its Q2 Release
Altria Group (MO) reported its second-quarter results yesterday. Its stock fell to a low of $47.35 before closing at $48.50.
Altria’s Q2 Revenue Tops Estimates, Earnings In Line
Today, Altria Group (MO) reported its second-quarter earnings results. In the quarter, the company had adjusted EPS of $1.10.
Could Altria’s Q2 Results Boost Its Stock Price?
Altria Group (MO) is set to report its second-quarter earnings before the market opens on July 30. In the quarter, analysts expect the company’s revenue and EPS to rise.
Philip Morris Rises Over 8% After Its Impressive Q2 Results
Philip Morris International (PM) reported its second-quarter earnings results on Thursday. The company reported adjusted EPS of $1.46.
Altria Rises After Goldman Sachs Calls It a ‘Buy’
On Friday, Goldman Sachs upgraded Altria Group (MO) from a “neutral” to a “buy” while keeping its price target unchanged at $59.
Has Philip Morris Stock Bottomed Out?
Philip Morris International (PM) was trading at $77.38, which represents a fall of 9.5% since its first-quarter earnings on April 18.
Altria’s Valuation Multiple Compared to Its Peers
As of June 21, Altria was trading at a forward PE ratio of 11.1x—compared to 12.8x before its first-quarter earnings were announced. Altria posted its first-quarter earnings on April 25.
Why Did Altria Stock Fall 4.5% on June 21?
Scott Gottlieb’s comments might have led to a fall in Altria’s stock price on June 21. At the closing on June 21, the company was trading at $48.00—a fall of 4.5% from the previous day’s closing price.
Altria Stock Rose Due to Acquiring Burger Sohne Stake
On June 3, Altria Group (MO) announced that it signed a definitive agreement to acquire 80% of the stake in Burger Söhne Holding.
Altria’s Earnings: Analysts’ Expectations in 2019
For 2019, Altria’s management expects the company to post a diluted EPS of $4.15–$4.27, which represents 4%–7% growth from $3.99 in 2018.
Altria Has Fallen ~8.0% since Its Last Earnings: What’s Next?
As of May 30, Altria Group (MO) was trading at $50.21—a fall of 8.2% since its first-quarter earnings on April 25.
How Altria and Philip Morris’s Valuation Multiples Compare
Altria Group (MO) reported its first-quarter earnings on April 25.
Why Tobacco Stocks Fell on May 28
On May 28, Altria Group (MO) fell 4.8%, while British American Tobacco (BTI) fell 4.1%.
How Does Philip Morris’s Valuation Multiple Compare with Peers?
Today, Philip Morris International (PM) was trading ~0.8% higher at 11:05 AM EST.
What Led Altria’s Revenue to Fall in Q1 2019?
For the first quarter of 2019, Altria Group (MO) has posted revenue, net of excise tax, of $4.39 billion against analysts’ estimate of $4.59 billion.
Altria Fell ~6% after Posting Disappointing Q1 Earnings
Altria failed to meet analysts’ revenue and EPS expectations for the first quarter.
Philip Morris Stock Fell despite Strong Q1 Results
Despite strong first-quarter results, Philip Morris was trading in the red early on April 18.
Can IQOS Sales Drive Philip Morris’s Revenue in Q1 2019?
Analysts expect Philip Morris International (PM) to post revenue of $6.74 billion in the first quarter.
Consumer Staples Stocks: Stragglers in Q1
Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.
Altria’s Valuation Multiple Compared to Its Peers
As of April 3, Altria was trading at a forward PE ratio of 12.7x—compared to 13.3x before the FDA’s announcement.
Why Did Altria Stock Fall ~4.8% on April 3?
The FDA’s announcement caused Altria’s stock price to fall. On April 3, the stock price fell to a low of $53.43 before closing the day at $53.98.
Why Tobacco Stocks Registered Impressive Gains in Q1
Sin stocks marked healthy growth in the first quarter. Molson Coors and Brown-Forman stocks rose 6.2% and 10.9%, respectively.
These Consumer Staples Stocks Marked Stellar Gains in Q1
The Consumer Staples Select Sector SPDR ETF (XLP) rose 10.5% in the first quarter of 2019.
Why Analysts Are Expecting Philip Morris’s Revenue to Rise in 2019
For 2019, analysts are expecting Philip Morris International (PM) to post revenue of $30.68 billion, which represents a rise of 3.6% from $29.63 billion in 2018.
Philip Morris Outperformed Altria’s Revenue Growth in 2018
Philip Morris International (PM) posted a net revenue excluding excise tax of $29.63 billion in 2018.
Altria Completed Its Investment in Cronos Group
On March 8, Altria (MO) announced that it completed its previously announced investment of ~$1.8 billion in Cronos Group.
Gundlach Forgot about the Intellectual Property Side of Cannabis
In an interview with Yahoo Finance, Jeffrey Gundlach described cannabis as a commodity like corn, implying that it has no intellectual property potential.
What Wall Street Expects of Philip Morris’s Revenue in 2019
For 2019, analysts expect Philip Morris International (PM) to report revenue of $30.69 billion, which represents growth of 3.6% from $29.63 billion in 2018.
Philip Morris: Valuation Multiple versus Peers
The strengthening broader equity market and strong fourth-quarter earnings have increased Philip Morris’s (PM) stock price, which has led to an increase in its valuation multiple.
Philip Morris Stock Up ~30% this Year: More Upside?
After losing 36.8% of its stock value in 2018, Philip Morris International (PM) began 2019 on a strong note.
Altria’s Stock Price Rose More than 2% on February 22
According to a Bloomberg report on February 22, JUUL Lab’s management expects its revenues to rise to $3.4 billion in 2019.
What Drove Pyxus International’s Revenue in Q3 2019?
In the third quarter of fiscal 2019, Pyxus International (PYX) posted revenue of $524.5 million, a rise of 9.8% year-over-year.
Why Pyxus International Stock Rose Over 33% after Its Q3 Results
Pyxus International (PYX) posted its fiscal 2019 third-quarter earnings results after the market closed on February 11.
How Altria Could Benefit from Its Cronos Group Investment
On December 7, Altria Group (MO) announced that it had invested $1.8 billion in Cronos Group (CRON) for a 45% stake in the company, which could increase 10% over the next four years.
Digging Deep into Altria’s Investment in JUUL Labs
On December 20, Altria Group (MO) announced a $12.8 billion investment in JUUL Labs for a 35% stake in the e-cigarette company.
Why Altria Is Betting Big on JUUL Labs and Cronos Group
In December, Altria Group (MO) made two big announcements. First, on December 7, Altria announced that it would invest $1.8 billion in Cronos Group (CRON).
Strong Fourth-Quarter Earnings Drove Philip Morris Stock
In the fourth quarter, Philip Morris outperformed analysts’ EPS estimate of $1.16 and revenue estimate of $7.39 billion.